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Introduction 
Asthma has been reported to complicate 1 % of pregnancies and increase 
the likelihood of prematurity and low birth weight (Cordon et aI, 1970). 
Pregnancy itself may alter the course of asthma. In general, one third of 
women feel that their asthma improves during pregnancy, one third feel 
that it deteriorates, while another third feel that pregnancy has no 
effect on their asthma (Weinstein et aI, 1979). 
The management of asthma in the pregnant patient does not differ 
greatly from that in patients who are not pregnant. Although it is wise 
to avoid all drugs, especially in the first trimester, it is important to 
remember that the potential hazards of uncontrolled asthma are much 
more likely to endanger the life of both mother and foetus (DiMarco. 
1989). Regular visits, during which asthma severity and therapeutic 
responsiveness are assessed, both objectively (with pulmonary function 
tests) and subjectively, are recommended in order to achieve the desired 
therapeutic goals in asthmatic females who require regular medication 
during pregnancy (5hatz et aI, 1991). 
To try and evaluate the situation in Malta, the aims of this study were 
to: 
1. Investigate the effect of asthma on the outcome of pregnancy over 
the past 5 years. 
2. Determine, subjectively, the effect of pregnancy on the course of 
asthma and carry out a preliminary study on the incidence of 
premenstrual exacerbation of asthma. 
3. Determine how the asthmatic pregnant patient is managed at the 
Ante Natal Clinic at 5t Luke's Hospital (5LH) and establish the 
importance of the clinical pharmacist in this area. 
4. Investigate the management and attendance of pregnant asthmatic 
women at the Asthma and Allergy Clinic at 5LH. 
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Methodology 
Studyl 
Retrospective Study 
The effect of asthma on the outcome of pregnancy was studied 
retrospectively from the medical histories of 106 women with a history 
of asthma who gave birth between January 1987 and September 1991. 
These subjects were obtained by going through the birth records (where 
any condition the mother suffered from was noted) for that period and 
through the Computer Centre at St Luke's Hospital. 
The women were classified as 'very mild', 'mild' 'moderately severe' and 
'severe' (Groups I to IV respectively, depending on the treatment and 
severity of their asthma during their pregnancy. Group I was further 
split into A and B, group A being those women not requiring any treatment 
at all. The number of females in each of the Groups lA, IB, Il, III, IV were 
42,33, 12, 11 and 8 respectively. 
Parameters investigated included: birth outcome, birthweight, 
maturity, miscarriage, Apgar score, occurrence of malformations, transfer 
to the Special Care Baby Unit (SCBU), type of delivery and drugs used 
during labour. In the case of the birth of more than 1 child during this 
period, the most recent birth was used in this study. 
These parameters were compared to those obtained for a control sample 
of an equal number of normal, non-asthmatic women picked at random 
from the birth records. The mean age of the women was 27 years in both 
asthmatic and control groups, with an age range of 16-42 and 16-37 
respecti vely. 
Trends in smoking during pregnancy were also studied in the group of 
asthmatic women but not compared with the controls. 
The results of this study were subjected to statistical analysis using 
Student's t-test and the Chi Square test. 
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Study 2 
Survey to pregnant asthmatic women 
The effect of pregnancy on the course of asthma was investigated by 
conducting a survey to 37 pregnant asthmatic women who had been 
registered at the Ante-Natal Clinic (ANC) between June and December 
1991. The subjects were obtained by going through all the files in the 
ANC to find out which patients had been registered as asthmatic when 
booking ante-natal care and enlisting the help of the nurses of booking 
the women in. 
The survey was a verbal one conducted by patient interview at the ANC 
or, for the most part, by telephone. Questions were set to determine the 
women's asthmatic characteristics; age of onset, family history, trigger 
factors, medication anci severity (mild, moderate or severe). Women 
were also asked about their smoking habits and the occurrence of asthma 
during pregnancy and its medication. The main aspect of this survey was 
about the course of their asthma during their current pregnancy and 
whether it was similar between successive pregnancies. 
This survey also included a preliminary study on the exacerbation of 
asthma premenstrually. 
Study 3 
Questionnaire to Obstetricians 
A questionnaire about the management of asthma during pregnancy was 
distributed to 30 obstetricians and obstetricians-in-training. The 
questions were set to determine if, when and how they treat and monitor 
this condition, their opinion about collaboration with a chest specialist 
and their ideas about the features being investigated in Studies 1 and 2. 
This questionnaire was also intended to obtain their views about the role 
of the clinical pharmacist in the assessment, thereapeutic management, 
monitoring and education of these patients. 
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Study 4 
A visit was paid to the Asthma and Allergy Clinic to determine the aims 
of. the clinic and how they are achieved. The attendance of pregnant 
asthmatic women was also investigated. 
Results 
Study 1 
Outcome of pregnancy: all the births were live births with no apparent 
malformations, both in the asthmatic and control groups. 
Table 1: Clinical characteristics of newborn infants of asthmatic and 
control women 
Asthmatic Patients Control 
Groups I, II Groups Ill, IV 
Number of infants 89* 19 106 
Gestational age 275 (9) 277 (17) 278 (11) 
(days, mean [SO]) 
Birth weight 3278 (399) 3145 (697) 3339 (491) 
(grams, mean [SO]) 
Abgar score <6 4 (4.5%) 5 (26.8%) 6 (5.7%) 
at 1 :n;in (%) 
Transferred to 5CBU (%) 1 (1.1 %) 1 (5.3%) 3 (2.8%) 
* 2 women had twins 
Labour and delivery: labour was induced in 54.7% of the asthmatic 
women and 17% of the control women. 8 of the births in each group were 
by Caesarean section and in both groups, 3 of them elective. Forceps were 
used in 4 births of the asthmatic group, but in only 1 of the control group. 
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All deliveries were otherwise normal and all had a cephalic 
presentation except for 1 case in the asthmatic group which was breech. 
Ergotocin was used after 70 'asthmatic' deliveries and 100 control 
deliveries, while pethidine and sparine were used in 41 and 65 women 
respectively. 
Miscarriage: Taking all past births and miscarriages of all the women, 
the incidence of miscarriage was 8.4% in both groups. 
Smoking trend: 16 of the asthmatic women smoked. The mean birth 
weight of their infants was slightly lower than the rest. 
The gestation period of women in Group IV was significantly (p<5) 
shorter than that in the control group. On the other hand, the 
gestational period in Group III was significantly (p<5) longer than that 
in both Groups r and H. 
The birth weight of infants in group IV was significantly (p<l) lower 
than that of those in Group I and the control group. 
A significantly higher percentage of neonates from Groups III and IV 
were transferred to the SeBU than from Group I and the control group. 
Group I also had a significantly lower percentage of neonates in the 
SeBU than Group H (p<5). 
Study 2 
The mean age of the women was 28 years (range: 19-40). The mean age of 
onset was 14.5 years, ranging from early infancy «1) to adulthood (36). 
It resulted that 9 of the women (24%) associated pregnancy with their 
becoming asthmatic, although 1 of these women had already been 
asthmatic in her childhood. 
Twenty-two women used a bronchodilator aerosol during pregnancy. 
Eight were taking inhaled steroids, one inhaled cromoglycate, five oral 
bronchodilator therapy and the woman with severe asthma was on oral 
corticosteroids. Twelve women were taking no anti-asthmatic therapy at 
all during pregnancy. Three women, all in the 'moderate' group, required 
nebuliser therapy during pregnancy, but no hospitalisation was required 
for any of the women. The subjective course of asthma in 37 women is 
shown in Figure 1. 
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Figure 1: Subjective course of asthma in37 pregnancies 
Improved 
The present pregnancy was the first for 10 of the women, while another 8 
were not yet asthmatic in their first pregnancy. In 10 (63%) of the 
remaining 27, asthma followed the same course as in the immediately-
preceding pregnancy. 
24 (65%) had an allergic basis to their asthma, 18 (49%) had a family 
history of asthma or of allergy and 4 (11 %) of the women smoked during 
pregnancy. 
14 women (38%) were aware of a premenstrual exacerbation of their 
asthma, including all 3 women whose asthma deteriorated during 
pregnancy. 
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Study 3 
The questionnaire to obstetricians had a 46.7% response. Each respondent 
sees less than 20 asthmatic, pregnant women per year, 71 % seeing less 
than 10. The patient is determined as asthmatic by means of patient 
interview, medical file and physical examination, but only 4 respondents 
would use pulmonary function tests to assess asthma severity. 
The majority (71 %) consider the prevention of an asthmatic attack more 
important than possible complications of treatment, yet only half of 
these would start treatment immediately. Generally, normal anti-
asthmatic treatment is continued, or the asthma is treated according to 
its severity. Therapy comprises: inhaled beta-2 agonists (100%), oral 
beta-2 agonists (64%), inhaled corticosteroids (29%) and prophylactiC 
agents (7%). Drugs avoided during pregnancy are shown in Figure 3. 
Systemic corticosteroids are avoided mainly because of teratogenic risk to 
the foetus and because of foetal adrenal gland suppression (25%). 
Obstetric drugs that are avoided in asthmatic patients are also shown in 
Figure 2. 
11 (79%) respondents thought that regular consultation with a chest 
specialist would be beneficial to. the asthmatic patient, but only 5 refer 
such patients on the first ante-natal visit. Monitoring of progress by 
means of pulmonary function testing is carried out by only 4 (29%) of the 
respondents, since they are mostly used when the patient is admitted to 
hospital for an exacerbation of asthma (79%). 
The opinion of the effect of asthma and anti-asthmatic drugs on 
pregnancy is shown in Figure 3, while that on the effect of pregnancy on 
asthma is shown In Figure 4. 
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Figure 2: Drugs avoided in the pregnant asthmatic patient 
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Figure 3: Opinion of the effect of asthma on pregnancy 
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Figure 4: Opinion on the effect of pregnancy on asthma 
Of the 64% who thought that gestation age was likely to affect asthma 
severity, 55% thought asthma deteriorated in the last 4 weeks of 
pregnancy. Exactly half agreed that asthma may have a menstrual 
rhythm. 
The opinion of the obstetricians on the role of the clinical pharmacist in 
the management of asthma during pregnancy is shown in Figure 5. 
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Figure 5: Opinion of the role of the Clinical Pharmacist in the 
management of asthma during pregnancy 
297 
Study 4 
This visit showed that so far, only two pregnant asthmatic patients 
have been to the clinic, only 1 of these having been referred by the 
Department of Obstetricians and Gynaecologists. The main aims of the 
clinic are to reduce asthma symptoms as much as possible and bring 
pulmonary function testing back to normal by regular consultation visits 
and pulmonary function testing (FEV, FVC, PEFR). It resulted that all 
asthmatic pregnant patients would be better off if they visited this clinic 
regularly. 
Conclusion 
Asthma, when well-controlled, seemed to have precipitated no real 
emergencies with respect to birth outcome, during the past five years. 
65% of asthmatic women appear to improve during pregnancy, while the 
fact that 38% suffer from premenstrual asthma contributes further to the 
existence of this relationship (not invariably accepted). The pharmacist 
may haye an important role as a link between the chest specialist and 
the obstetrician and even more so in educating the patient about her 
asthma and its treatment. This service would optimize the management 
of asthma during pregnancy and hence, the mother's health and the 
outcome of birth. 
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